Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 12Peritoneal Neoplasms 9Stomach Neoplasms 8Neoplasm Metastasis 7Colorectal Neoplasms 7Fallopian Tube Neoplasms 5Endometrial Neoplasms 5Triple Negative Breast Neoplasms 4Colonic Neoplasms 4Carcinoma, Renal Cell 4Carcinoma, Non-Small-Cell Lung 4Squamous Cell Carcinoma of Head and Neck 3Rectal Neoplasms 3Neoplasms 3Melanoma 3Esophageal Neoplasms 3Uterine Neoplasms 2Urinary Bladder Neoplasms 2Pseudomyxoma Peritonei 2Pancreatic Neoplasms 2Lung Neoplasms 2Gestational Trophoblastic Disease 2Cholangiocarcinoma 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Appendiceal Neoplasms 2Vipoma 1Uterine Cervical Neoplasms 1Teratoma, Ovarian 1Somatostatinoma 1

Interventions

Methotrexate 1Leucovorin 1Dactinomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hydatidiform Mole, Invasive × Leucovorin × Gynecologic × Clear all
NCT04562558 2025-08-11

Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia

Peking Union Medical College Hospital

Phase NA Active not recruiting
228 enrolled
Gynecologic

Hydatidiform Mole, Invasive, Choriocarcinoma, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡